文献速递血栓与止血

猪、牛、羊源肝素免疫原性风险评估

Immunogenic risk assessment of porcine, bovine, and ovine heparins for diversifying the global heparin supply.
PubMed 文献 · J Thromb Haemost · 2026-07-18

该研究系统评估了猪黏膜、牛肺和羊黏膜肝素及其低分子量肝素衍生物的PF4依赖免疫原性。在等效剂量下,PF4复合物形成、抗体识别和血小板活化顺序为牛肺>羊黏膜>猪黏膜;低分子量肝素在效价归一化后仍存在来源差异。研究为肝素诱导的血小板减少症风险机制提供了见解,并支持全球肝素供应多元化。

要点

  • 牛肺肝素免疫原性高于羊黏膜和猪黏膜肝素。
  • 低分子量肝素效价归一化后牛源仍显示更强血小板活化。
  • dp6-dp8为最小PF4结合单元,硫酸化增强亲和力。

核心结论

  • 不同动物来源肝素具有 distinct PF4结合特性和免疫原性特征。

研究设计与样本

  • 采用尺寸排阻色谱和竞争ELISA监测PF4-肝素复合物化学计量和抗体识别。
  • 流式细胞术定量功能性肝素诱导的血小板活化(CD62P/CD63表达)。
  • PF4亲和色谱-亲水相互作用液相色谱-质谱和分子对接表征高亲和力聚糖特征。

主要发现

  • 在等效剂量条件下,PF4复合物形成、抗体识别和血小板活化顺序为牛肺肝素>羊黏膜肝素>猪黏膜肝素。
  • 肝素间差异主要由分子量依赖的化学计量解释。
  • 低分子量肝素在效价归一化后来源差异持续,牛低分子量肝素形成显著更多PF4复合物并触发最强血小板活化。
  • 亲和谱鉴定聚合度6至8(dp6-dp8)为最小PF4结合单元,增加硫酸化和减少N-乙酰化增强PF4亲和力。
  • 分子对接证实N-硫酸化稳定PF4-肝素相互作用。

临床怎么用

  • 临床选择肝素时需考虑动物来源对免疫原性的潜在影响。
  • 支持全球肝素供应多元化策略。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The global heparin supply relies heavily on porcine mucosa, prompting renewed interest in ruminant-derived alternatives. However, concerns regarding heparin-induced thrombocytopenia remain a major barrier to their clinical reintroduction. OBJECTIVES: To systematically evaluate the platelet factor 4 (PF4)-dependent immunogenic potential of porcine mucosal heparin, bovine lung heparin, and ovine mucosal heparin, as well as their low-molecular-weight heparin (LMWH) derivatives, and to delineate the structural features governing these interactions. METHODS: Size-exclusion chromatography and a competitive ELISA established in this study were used to monitor PF4-heparin complex stoichiometry and antibody recognition. Flow cytometry quantified functional heparin-induced platelet activation (CD62P/CD63 expression). PF4 affinity chromatography-hydrophilic interaction liquid chromatography-mass spectrometry and molecular docking characterized high-affinity glycan features and evaluated sulfation patterns in stabilizing PF4-heparin interactions. RESULTS: Under equipotent dosing conditions, PF4 complex formation, antibody recognition, and platelet activation followed the order bovine lung heparin > ovine mucosal heparin > porcine mucosal heparin. Differences among heparins were largely explained by molecular weight-dependent stoichiometry. In contrast, source-dependent differences among LMWHs persisted after potency normalization, with bovine LMWH forming significantly more PF4 complexes and triggering the most robust platelet activation. Affinity profiling identified degree of polymerization 6-degree of polymerization 8 (dp6-dp8) as minimal PF4-binding units and revealed that increased sulfation and reduced N-acetylation enhance PF4 affinity. Molecular docking confirmed that N-sulfation stabilizes PF4-heparin interactions. CONCLUSION: Heparins derived from different animal sources exhibit distinct PF4-binding properties and immunogenic profiles. These findings provide mechanistic insight into species-dependent heparin-induced thrombocytopenia risk-driven by stoichiometry in heparin and fine structural features in LMWH-and support diversification of the global heparin supply.

来源:J Thromb Haemost,查看原文。版权归原作者所有。

引用

  1. Zhang B, Bu C, Geng Y, et al. Immunogenic risk assessment of porcine, bovine, and ovine heparins for diversifying the global heparin supply. J Thromb Haemost. 2026. PMID: 42471057. doi:10.1016/j.jtha.2026.07.009

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。